{
  "name": "Vertex Pharmaceuticals",
  "slug": "vertex-pharmaceuticals",
  "ticker": "VRTX",
  "fetched_at": "2025-09-01T12:22:53.818080+00:00",
  "news": [
    {
      "title": "Using Bollinger Bands to evaluate Vertex Pharmaceuticals Incorporated - July 2025 Short Interest & Low Risk High Reward Ideas - Newser",
      "link": "https://news.google.com/rss/articles/CBMioAFBVV95cUxPM2otT0pqcW9ZX2w2eElLcWZxby16QzkzTG1XdzJ5SnNibHB1OVJfbkJyR3Q4M3JzWFFuUFZ1T2cxelBVTmMxUnNqN1ZWZDZJd1QxUDlWUTY1M0J1SU9aS29SNzVzellDT24wX0pWVzZ5SlFLeW9iZWtkTjNrTjNuclRmQTlzUGhXTGNNbHN0QnBhMG5tbktXczR2cU5wTUVR?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMioAFBVV95cUxPM2otT0pqcW9ZX2w2eElLcWZxby16QzkzTG1XdzJ5SnNibHB1OVJfbkJyR3Q4M3JzWFFuUFZ1T2cxelBVTmMxUnNqN1ZWZDZJd1QxUDlWUTY1M0J1SU9aS29SNzVzellDT24wX0pWVzZ5SlFLeW9iZWtkTjNrTjNuclRmQTlzUGhXTGNNbHN0QnBhMG5tbktXczR2cU5wTUVR?oc=5\" target=\"_blank\">Using Bollinger Bands to evaluate Vertex Pharmaceuticals Incorporated - July 2025 Short Interest & Low Risk High Reward Ideas</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Newser</font>",
      "published": "2025-08-31T19:17:26+00:00",
      "source": "Newser"
    },
    {
      "title": "Stock Analysis | Vertex Pharmaceuticals Outlook - Mixed Signals Amid Changing Market Dynamics - AInvest",
      "link": "https://news.google.com/rss/articles/CBMiuwFBVV95cUxORWRJcUVjbGh6Q0huY3FJbTlqX19qMXAzWWVwU25OWk1rM0lxbVVlT01keWFTbFYxU01vTy1FTFlhQ283aVN0aEgxZ3c4Z18zUmxBY1RCZkpPZ2FZQjBPbEROb20xSW5uOW1HUWIzX2ZRRE1rTG5pd2V5RTM4Um5IU2VjVEx6ZWRSM2t2Yk8zSnJRZC0yYmlCM1JrMXk5S0t6VjUyU1IyNTloSmY4X0FjdEF6R2lxVVR6Sk9B?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMiuwFBVV95cUxORWRJcUVjbGh6Q0huY3FJbTlqX19qMXAzWWVwU25OWk1rM0lxbVVlT01keWFTbFYxU01vTy1FTFlhQ283aVN0aEgxZ3c4Z18zUmxBY1RCZkpPZ2FZQjBPbEROb20xSW5uOW1HUWIzX2ZRRE1rTG5pd2V5RTM4Um5IU2VjVEx6ZWRSM2t2Yk8zSnJRZC0yYmlCM1JrMXk5S0t6VjUyU1IyNTloSmY4X0FjdEF6R2lxVVR6Sk9B?oc=5\" target=\"_blank\">Stock Analysis | Vertex Pharmaceuticals Outlook - Mixed Signals Amid Changing Market Dynamics</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">AInvest</font>",
      "published": "2025-09-01T03:20:31+00:00",
      "source": "AInvest"
    },
    {
      "title": "Maze Therapeutics referred to federal marketing regulators over challenge brought by Vertex - Fierce Pharma",
      "link": "https://news.google.com/rss/articles/CBMiwgFBVV95cUxPZjdyaUNqT19CamJOMUJfX0FwM00tdW5BRjBKMjdwRWdQb1JVemxTYmp2cjFHdVhwT0V4OHh2SDFtTXNCelVHVWxnWlNNTUxCa2duYlJqODh5NmNKalpGWUg3LXZ2Y0YyNS1JYjZIWkNRVFpaNTBNYTl2b2ViNGxWLUdyU2xscFlLZ0p2RENFT1RCbWVkZE9ManJ5aERzYmVaWEtpNy1MVXFhX2hXbEFYMG1iMXZVWmhDdVBXakR0U0trdw?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMiwgFBVV95cUxPZjdyaUNqT19CamJOMUJfX0FwM00tdW5BRjBKMjdwRWdQb1JVemxTYmp2cjFHdVhwT0V4OHh2SDFtTXNCelVHVWxnWlNNTUxCa2duYlJqODh5NmNKalpGWUg3LXZ2Y0YyNS1JYjZIWkNRVFpaNTBNYTl2b2ViNGxWLUdyU2xscFlLZ0p2RENFT1RCbWVkZE9ManJ5aERzYmVaWEtpNy1MVXFhX2hXbEFYMG1iMXZVWmhDdVBXakR0U0trdw?oc=5\" target=\"_blank\">Maze Therapeutics referred to federal marketing regulators over challenge brought by Vertex</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Fierce Pharma</font>",
      "published": "2025-08-28T14:49:42+00:00",
      "source": "Fierce Pharma"
    },
    {
      "title": "Vertex Pharmaceuticals Incorporated Builds Base for Possible Rebound getLinesFromResByArray error: size == 0 - thegnnews.com",
      "link": "https://news.google.com/rss/articles/CBMiqAFBVV95cUxOa3lZb2R5aTdjc00xU19GUTZfdkVPQkxVUGtLTW5SWWk2SHNSUlBQUVdIU2hXZmNnRldnNkRtMzdFWDlLM3ZIVExXdjAyWjZPNmFNNUxiZnhNLURkSVFVR2szX1o2NzlZMjdEOU9YNFFuZzlfSkc4aWJsbEtJcDdXeHBWUmFRdzJycFp4X2ZRb0tnNVBXZ3A2dTlDdWoxbzBZWWZuN2hGWGM?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMiqAFBVV95cUxOa3lZb2R5aTdjc00xU19GUTZfdkVPQkxVUGtLTW5SWWk2SHNSUlBQUVdIU2hXZmNnRldnNkRtMzdFWDlLM3ZIVExXdjAyWjZPNmFNNUxiZnhNLURkSVFVR2szX1o2NzlZMjdEOU9YNFFuZzlfSkc4aWJsbEtJcDdXeHBWUmFRdzJycFp4X2ZRb0tnNVBXZ3A2dTlDdWoxbzBZWWZuN2hGWGM?oc=5\" target=\"_blank\">Vertex Pharmaceuticals Incorporated Builds Base for Possible Rebound getLinesFromResByArray error: size == 0</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">thegnnews.com</font>",
      "published": "2025-09-01T08:47:10+00:00",
      "source": "thegnnews.com"
    },
    {
      "title": "Vertex Pharmaceutical Stock Dives as Firm to Stop Developing Acute Pain Drug - Investopedia",
      "link": "https://news.google.com/rss/articles/CBMitAFBVV95cUxPSm1iMzM5VjEteHhaVHNhempsaUUwVmJzc3NmSlpVRnhkeWRVWmhlR2d3b0RZMzhZdXdzT28wU0FtbUczSXNoUDZCMnJPZGk5ZERFYVh4Z2RmZ3ZzOUM3QTdwc0tQdDFWR092VjIwSllxNWdpTE1OUTRxcVVKMzR4aURwZmVkdENiWHBsVi1PcGJ2cy1ab0NpUHVoN2QwdFYzYldTMnNLc2lrUEV3bm1MSlVaTG0?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMitAFBVV95cUxPSm1iMzM5VjEteHhaVHNhempsaUUwVmJzc3NmSlpVRnhkeWRVWmhlR2d3b0RZMzhZdXdzT28wU0FtbUczSXNoUDZCMnJPZGk5ZERFYVh4Z2RmZ3ZzOUM3QTdwc0tQdDFWR092VjIwSllxNWdpTE1OUTRxcVVKMzR4aURwZmVkdENiWHBsVi1PcGJ2cy1ab0NpUHVoN2QwdFYzYldTMnNLc2lrUEV3bm1MSlVaTG0?oc=5\" target=\"_blank\">Vertex Pharmaceutical Stock Dives as Firm to Stop Developing Acute Pain Drug</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Investopedia</font>",
      "published": "2025-08-05T07:00:00+00:00",
      "source": "Investopedia"
    },
    {
      "title": "Vertex Pharmaceuticals: The Stock Hasn't Dropped Enough Yet (NASDAQ:VRTX) - Seeking Alpha",
      "link": "https://news.google.com/rss/articles/CBMimgFBVV95cUxNeHYzalNfR1E1cWFrb0Y1SFYxMXQyNnJwV05BcGh3OWk2d21XYzBSYTAtbHZfT25tdFJZRU1uR1lsNXpoeGNENS1mMDZrdmVLRmVZMUZSWmZBOUM0dC1CUU9yOW1vV0J2VWdqbVN4eHotLW90NlF0U3E5TjFIaGVUYVkxakltamVrZjJPQlZ1Nk1PX2gyZUdCOEl3?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMimgFBVV95cUxNeHYzalNfR1E1cWFrb0Y1SFYxMXQyNnJwV05BcGh3OWk2d21XYzBSYTAtbHZfT25tdFJZRU1uR1lsNXpoeGNENS1mMDZrdmVLRmVZMUZSWmZBOUM0dC1CUU9yOW1vV0J2VWdqbVN4eHotLW90NlF0U3E5TjFIaGVUYVkxakltamVrZjJPQlZ1Nk1PX2gyZUdCOEl3?oc=5\" target=\"_blank\">Vertex Pharmaceuticals: The Stock Hasn't Dropped Enough Yet (NASDAQ:VRTX)</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Seeking Alpha</font>",
      "published": "2025-08-12T07:00:00+00:00",
      "source": "Seeking Alpha"
    },
    {
      "title": "Meet the 2025 Vertex Science Leaders Scholarship recipients - Vertex Pharmaceuticals",
      "link": "https://news.google.com/rss/articles/CBMijgFBVV95cUxOTXFmVmwtdVAyTUY5QkFBSExaYjh0WXlGeFZrQWYzZDlBWnFoY0dCR0NXNVI4d1BXbmpZUF90SUdQVGxTN3JUOVNEVEZmYWgyb0lMc1d6NHBpR2J1dmd6a3VKSGRlVGprVGZ0Q2FITnRCOXZTMEZwWXRRTVY1R1EzeFFNWUpodUlidzJGYUd3?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMijgFBVV95cUxOTXFmVmwtdVAyTUY5QkFBSExaYjh0WXlGeFZrQWYzZDlBWnFoY0dCR0NXNVI4d1BXbmpZUF90SUdQVGxTN3JUOVNEVEZmYWgyb0lMc1d6NHBpR2J1dmd6a3VKSGRlVGprVGZ0Q2FITnRCOXZTMEZwWXRRTVY1R1EzeFFNWUpodUlidzJGYUd3?oc=5\" target=\"_blank\">Meet the 2025 Vertex Science Leaders Scholarship recipients</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Vertex Pharmaceuticals</font>",
      "published": "2025-08-25T13:08:07+00:00",
      "source": "Vertex Pharmaceuticals"
    },
    {
      "title": "TIME100 Most Influential Companies 2025: Vertex Pharmaceuticals - Time Magazine",
      "link": "https://news.google.com/rss/articles/CBMiiwFBVV95cUxQVkY3MnJaQ3p3Mk5LZGVBRXhDY0ZmaF9CS21MZWJSb01RRTNUN0JHUE9lTGRrckh6QnkxUGhXcm1yNk81WmM5aVdxZVdTdEFTMTBaN0E0MndpNHRLWjBJd2RrZ09JT3ZDaE04d21ucmVkcnl4aGFIcFlaN1QxcGtiT1lYQ2ppX202b2pr?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMiiwFBVV95cUxQVkY3MnJaQ3p3Mk5LZGVBRXhDY0ZmaF9CS21MZWJSb01RRTNUN0JHUE9lTGRrckh6QnkxUGhXcm1yNk81WmM5aVdxZVdTdEFTMTBaN0E0MndpNHRLWjBJd2RrZ09JT3ZDaE04d21ucmVkcnl4aGFIcFlaN1QxcGtiT1lYQ2ppX202b2pr?oc=5\" target=\"_blank\">TIME100 Most Influential Companies 2025: Vertex Pharmaceuticals</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Time Magazine</font>",
      "published": "2025-06-26T07:00:00+00:00",
      "source": "Time Magazine"
    }
  ],
  "product_launches": [
    {
      "title": "Strong Product Launches and Upbeat Guidance Could Be a Game Changer for Vertex Pharmaceuticals (VRTX) - Yahoo Finance",
      "link": "https://news.google.com/rss/articles/CBMijgFBVV95cUxNOFZFNHZzSk1rSnJWVTEwWExLd1FvWVBPUkVkTV9TRG1oUWdTbWgzbWNkdlA3MkVLNmVra3NUUWhBQWFXZ3c5LVNxZFRkWDhkMUZ1QVlUXzg3ZEZwOHY3TTRjMEYxUjlwZFhYVW84QUVXX0lQaTZVbDN4Qk5WM1NQX0EwSVJXZ2piZXl4d3ZB?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMijgFBVV95cUxNOFZFNHZzSk1rSnJWVTEwWExLd1FvWVBPUkVkTV9TRG1oUWdTbWgzbWNkdlA3MkVLNmVra3NUUWhBQWFXZ3c5LVNxZFRkWDhkMUZ1QVlUXzg3ZEZwOHY3TTRjMEYxUjlwZFhYVW84QUVXX0lQaTZVbDN4Qk5WM1NQX0EwSVJXZ2piZXl4d3ZB?oc=5\" target=\"_blank\">Strong Product Launches and Upbeat Guidance Could Be a Game Changer for Vertex Pharmaceuticals (VRTX)</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Yahoo Finance</font>",
      "published": "2025-08-22T07:00:00+00:00",
      "source": "Yahoo Finance"
    },
    {
      "title": "Vertex Pharmaceuticals' Q2 Results: Robust Launches and Revenue Guidance - AInvest",
      "link": "https://news.google.com/rss/articles/CBMiowFBVV95cUxOTDdlM0tKUmUwRmRORXFhbWYxWVZOY2dTaXJVMDVwdHBua3Rsd0sxUFo0UDVhTDRPXzZjTjFtZ1Q2Nl9jYWVWZ203OGhXb21hWnoyWkpHWXBZUUgzLUUzRmttRkcwelhZMEd1ekk0NVlfa1JXNXhqRnV1U1ZJWkZGTU9rcEozWXN3SFRMeUI2U0l2UTVrN1hubmdkTjBGZXU0eEpF?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMiowFBVV95cUxOTDdlM0tKUmUwRmRORXFhbWYxWVZOY2dTaXJVMDVwdHBua3Rsd0sxUFo0UDVhTDRPXzZjTjFtZ1Q2Nl9jYWVWZ203OGhXb21hWnoyWkpHWXBZUUgzLUUzRmttRkcwelhZMEd1ekk0NVlfa1JXNXhqRnV1U1ZJWkZGTU9rcEozWXN3SFRMeUI2U0l2UTVrN1hubmdkTjBGZXU0eEpF?oc=5\" target=\"_blank\">Vertex Pharmaceuticals' Q2 Results: Robust Launches and Revenue Guidance</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">AInvest</font>",
      "published": "2025-08-22T07:00:00+00:00",
      "source": "AInvest"
    },
    {
      "title": "Vertex tops estimates on cystic fibrosis treatment strength, new products - Reuters",
      "link": "https://news.google.com/rss/articles/CBMi2AFBVV95cUxQV1RfcWFhZlB4RnlGTUNfYlJTOEFKaHREZHlEeV9GVHpnaW1zRDliVlMtX3dWdjZkS2RNRWhZaXc0NmdVcW10bVhmQV9NNlh3b3IwckhEME9rTFlIci1hRDF4RlFzRWprOWFTdjlVV1d4dVpIaVFGWXBiWF9tbnJmcFEydUxiNDF1TVJfLTI4QmtvcnIwWVhYd3hNTno2aFhpZF9WNFZjX3lJLVVsNjZfcWZOVTVzU2lXYzV1cmw0bDRpTUFiWjJLUElvRk15d1RKLWJnQy10MmU?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMi2AFBVV95cUxQV1RfcWFhZlB4RnlGTUNfYlJTOEFKaHREZHlEeV9GVHpnaW1zRDliVlMtX3dWdjZkS2RNRWhZaXc0NmdVcW10bVhmQV9NNlh3b3IwckhEME9rTFlIci1hRDF4RlFzRWprOWFTdjlVV1d4dVpIaVFGWXBiWF9tbnJmcFEydUxiNDF1TVJfLTI4QmtvcnIwWVhYd3hNTno2aFhpZF9WNFZjX3lJLVVsNjZfcWZOVTVzU2lXYzV1cmw0bDRpTUFiWjJLUElvRk15d1RKLWJnQy10MmU?oc=5\" target=\"_blank\">Vertex tops estimates on cystic fibrosis treatment strength, new products</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Reuters</font>",
      "published": "2025-08-04T07:00:00+00:00",
      "source": "Reuters"
    },
    {
      "title": "Vertex Pharmaceuticals: Promising Growth with Successful Launch and Strong Pipeline - TipRanks",
      "link": "https://news.google.com/rss/articles/CBMixwFBVV95cUxQWEN0dzJBekJiaFJYMm9qbVN5Q3djdThMV0VTSlI2aDRDSDM2ZHhCOHI5N3BxTzRMcnVRVzNBM05Sc21acGdKcXRhM01XTkdNT1QyLVRpWmFiMkJKb1lOZkxzMlBnbHFWbzAzUXdPNTBncG9ReGlkLXBMaFNIc1NRSTV1UjRxcUFmQ0RiTl9RUjJFdU9jQ0V0Si0wdW9mQ01ITWo1WVhzbUhEV253dmh4LVI0TnJvZ3BCVWNfNFFDVXowc0xvdU8w?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMixwFBVV95cUxQWEN0dzJBekJiaFJYMm9qbVN5Q3djdThMV0VTSlI2aDRDSDM2ZHhCOHI5N3BxTzRMcnVRVzNBM05Sc21acGdKcXRhM01XTkdNT1QyLVRpWmFiMkJKb1lOZkxzMlBnbHFWbzAzUXdPNTBncG9ReGlkLXBMaFNIc1NRSTV1UjRxcUFmQ0RiTl9RUjJFdU9jQ0V0Si0wdW9mQ01ITWo1WVhzbUhEV253dmh4LVI0TnJvZ3BCVWNfNFFDVXowc0xvdU8w?oc=5\" target=\"_blank\">Vertex Pharmaceuticals: Promising Growth with Successful Launch and Strong Pipeline</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">TipRanks</font>",
      "published": "2025-08-18T07:00:00+00:00",
      "source": "TipRanks"
    },
    {
      "title": "(suzetrigine), a First-in-Class Treatment for Adults With Moderate-to-Severe Acute Pain - Vertex Pharmaceuticals Newsroom",
      "link": "https://news.google.com/rss/articles/CBMivgFBVV95cUxQNGhZSnljSUNJSGJ4SzNPVXdNeXNncWRyT1dUWVY2VDVxWDFhamJGQUtSWlhJLVVJMmhSQjROckJNemJGZVlkY3ZmR0ZmYXBiX1J1ZHExdk1ZOW1wTWp5T1ZWa283c2RkYjdkUlgwMEtNejlNb3NJbVZJZlpyVmNweWptQ3dWeDAtV0NfVEJXNG5RU1pTZFRUY01hOEd0SXdwMXFTdEpGTnJTMklMX2NRUnBwUGhndjcyWUJzc0pn?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMivgFBVV95cUxQNGhZSnljSUNJSGJ4SzNPVXdNeXNncWRyT1dUWVY2VDVxWDFhamJGQUtSWlhJLVVJMmhSQjROckJNemJGZVlkY3ZmR0ZmYXBiX1J1ZHExdk1ZOW1wTWp5T1ZWa283c2RkYjdkUlgwMEtNejlNb3NJbVZJZlpyVmNweWptQ3dWeDAtV0NfVEJXNG5RU1pTZFRUY01hOEd0SXdwMXFTdEpGTnJTMklMX2NRUnBwUGhndjcyWUJzc0pn?oc=5\" target=\"_blank\">(suzetrigine), a First-in-Class Treatment for Adults With Moderate-to-Severe Acute Pain</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Vertex Pharmaceuticals Newsroom</font>",
      "published": "2025-01-30T08:00:00+00:00",
      "source": "Vertex Pharmaceuticals Newsroom"
    }
  ],
  "stock": {
    "ticker": "VRTX",
    "currency": "USD",
    "latest": {
      "date": "2025-08-29",
      "close": 391.0199890136719
    },
    "history": [
      {
        "date": "2025-08-21",
        "close": 397.4599914550781
      },
      {
        "date": "2025-08-22",
        "close": 395.1199951171875
      },
      {
        "date": "2025-08-25",
        "close": 388.94000244140625
      },
      {
        "date": "2025-08-26",
        "close": 387.17999267578125
      },
      {
        "date": "2025-08-27",
        "close": 389.0799865722656
      },
      {
        "date": "2025-08-28",
        "close": 392.04998779296875
      },
      {
        "date": "2025-08-29",
        "close": 391.0199890136719
      }
    ],
    "name": "Vertex Pharmaceuticals Incorpor"
  }
}